| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.036 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |